LON:C4XD C4X Discovery (C4XD) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About C4X Discovery Stock (LON:C4XD) 30 days 90 days 365 days Advanced Chart Remove Ads Get C4X Discovery alerts:Sign Up Key Stats Today's Range N/A50-Day Range 12▼ 1252-Week Range N/AVolume3.77 million shsAverage Volume1.18 million shsMarket Capitalization£30.27 millionP/E Ratio300.00Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewC4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.Read More… Remove Ads Receive C4XD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for C4X Discovery and its competitors with MarketBeat's FREE daily newsletter. Email Address C4XD Stock News HeadlinesPatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder populations in inflammatory bowel diseaseSeptember 17, 2024 | markets.businessinsider.comC4X Discovery Holdings PLC: C4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 22, 2024 | finanznachrichten.deTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 2, 2025 | Porter & Company (Ad)C4X Discovery Holdings PLC: C4X Discovery announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 22, 2024 | finanznachrichten.deC4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment of new Board membersJuly 22, 2024 | finance.yahoo.comUK biotech, what’s in it for retail investors?July 19, 2024 | ft.comC4X Discovery to Delist From AIM Due to Downturn in Financial MarketsMarch 27, 2024 | marketwatch.comAnother listed company plans to quit London’s AIM market – this is whyMarch 27, 2024 | msn.comSee More Headlines C4XD Stock Analysis - Frequently Asked Questions How were C4X Discovery's earnings last quarter? C4X Discovery Holdings plc (LON:C4XD) released its quarterly earnings data on Wednesday, April, 29th. The company reported ($5.02) earnings per share for the quarter, beating analysts' consensus estimates of ($5.50) by $0.48. C4X Discovery had a net margin of 42.81% and a trailing twelve-month return on equity of 55.38%. How do I buy shares of C4X Discovery? Shares of C4XD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of C4X Discovery own? Based on aggregate information from My MarketBeat watchlists, some other companies that C4X Discovery investors own include The Berkeley Group (BKG), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC) and Intel (INTC). Company Calendar Last Earnings4/29/2020Today4/02/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:C4XD CIKN/A Webwww.c4xdiscovery.com Phone+44-161-2355085FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.04 Trailing P/E Ratio300.00 Forward P/E RatioN/A P/E GrowthN/ANet Income£10.57 million Net Margins42.81% Pretax MarginN/A Return on Equity55.38% Return on Assets28.04% Debt Debt-to-Equity Ratio1.05 Current Ratio15.31 Quick Ratio9.82 Sales & Book Value Annual Sales£24.68 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow4.00 Book ValueGBX 10 per share Price / BookN/AMiscellaneous Outstanding Shares252,230,000Free FloatN/AMarket Cap£30.27 million OptionableNot Optionable Beta0.23 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (LON:C4XD) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4X Discovery Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share C4X Discovery With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.